146 related articles for article (PubMed ID: 12039657)
1. L-Arginine/nitric oxide pathway in chronic tension-type headache: relation with serotonin content and secretion and glutamate content.
Sarchielli P; Alberti A; Floridi A; Gallai V
J Neurol Sci; 2002 Jun; 198(1-2):9-15. PubMed ID: 12039657
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide pathway, Ca2+, and serotonin content in platelets from patients suffering from chronic daily headache.
Sarchielli P; Alberti A; Russo S; Codini M; Panico R; Floridi A; Gallai V
Cephalalgia; 1999 Nov; 19(9):810-6. PubMed ID: 10595291
[TBL] [Abstract][Full Text] [Related]
3. Variations in the platelet arginine/nitric oxide pathway during the ovarian cycle in females affected by menstrual migraine.
Sarchielli P; Tognoloni M; Russo S; Vulcano MR; Feleppa M; Malà M; Sartori M; Gallai V
Cephalalgia; 1996 Nov; 16(7):468-75. PubMed ID: 8933990
[TBL] [Abstract][Full Text] [Related]
4. L-arginine/nitric oxide pathway activation in platelets of migraine patients with and without aura.
Gallai V; Floridi A; Mazzotta G; Codini M; Tognoloni M; Vulcano MR; Sartori M; Russo S; Alberti A; Michele F; Sarchielli P
Acta Neurol Scand; 1996 Aug; 94(2):151-60. PubMed ID: 8891062
[TBL] [Abstract][Full Text] [Related]
5. Increased nitric oxide production in platelets from severe chronic renal failure patients.
Siqueira MA; Brunini TM; Pereira NR; Martins MA; Moss MB; Santos SF; Lugon JR; Mendes-Ribeiro AC
Can J Physiol Pharmacol; 2011 Feb; 89(2):97-102. PubMed ID: 21326340
[TBL] [Abstract][Full Text] [Related]
6. Effects of nutritional status on the L-arginine-nitric oxide pathway in platelets from hemodialysis patients.
da Silva CD; Brunini TM; Reis PF; Moss MB; Santos SF; Roberts NB; Ellory JC; Mann GE; Mendes-Ribeiro AC
Kidney Int; 2005 Nov; 68(5):2173-9. PubMed ID: 16221216
[TBL] [Abstract][Full Text] [Related]
7. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.
Radomski MW; Palmer RM; Moncada S
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5193-7. PubMed ID: 1695013
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension.
de Meirelles LR; Mendes-Ribeiro AC; Santoro MM; Mendes MA; da Silva MN; Mann GE; Brunini TM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1267-71. PubMed ID: 17973865
[TBL] [Abstract][Full Text] [Related]
9. Platelet hyperaggregability in obesity: is there a role for nitric oxide impairment and oxidative stress?
Leite NR; Siqueira de Medeiros M; Mury WV; Matsuura C; Perszel MB; Noronha Filho G; Brunini TM; Mendes-Ribeiro AC
Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):738-44. PubMed ID: 27145241
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the L-arginine-NO-cGMP pathway in spontaneously hypertensive rat platelets: the effects of pregnancy.
Ognibene DT; Moss MB; Matsuura C; Brunini TM; de Moura RS; Mendes-Ribeiro AC; Resende AC
Hypertens Res; 2010 Sep; 33(9):899-904. PubMed ID: 20555333
[TBL] [Abstract][Full Text] [Related]
11. Effects of non-surgical periodontal treatment on the L-arginine-nitric oxide pathway and oxidative status in platelets.
Siqueira MA; Fischer RG; Pereira NR; Martins MA; Moss MB; Mendes-Ribeiro AC; Figueredo CM; Brunini TM
Exp Biol Med (Maywood); 2013 Jun; 238(6):713-22. PubMed ID: 23918883
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the existence and biological role of L-arginine/nitric oxide pathway in human platelets by spin-trapping/EPR studies.
Prónai L; Ichimori K; Nozaki H; Nakazawa H; Okino H; Carmichael AJ; Arroyo CM
Eur J Biochem; 1991 Dec; 202(3):923-30. PubMed ID: 1662618
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet effect of amlodipine: a possible mechanism through a nitric oxide-mediated process.
Chou TC; Li CY; Yen MH; Ding YA
Biochem Pharmacol; 1999 Nov; 58(10):1657-63. PubMed ID: 10535758
[TBL] [Abstract][Full Text] [Related]
14. Low plasma levels of L-arginine, impaired intraplatelet nitric oxide and platelet hyperaggregability: implications for cardiovascular disease in depressive patients.
Pinto VL; de Souza PF; Brunini TM; Oliveira MB; Moss MB; Siqueira MA; Ferraz MR; Mendes-Ribeiro AC
J Affect Disord; 2012 Oct; 140(2):187-92. PubMed ID: 22424639
[TBL] [Abstract][Full Text] [Related]
15. 11,12-Epoxyeicosatrienoic acid activates the L-arginine/nitric oxide pathway in human platelets.
Zhang L; Cui Y; Geng B; Zeng X; Tang C
Mol Cell Biochem; 2008 Jan; 308(1-2):51-6. PubMed ID: 17932624
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the L-arginine:nitric oxide pathway in human platelets.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
[TBL] [Abstract][Full Text] [Related]
17. Modulation of human platelet function by L-canavanine: differential effects of low and high concentrations.
Anfossi G; Massucco P; Mattiello L; Cavalot F; Perna P; Giori A; Tassone F; Trovati M
Gen Pharmacol; 1999 Mar; 32(3):321-8. PubMed ID: 10211586
[TBL] [Abstract][Full Text] [Related]
18. Isosorbide-5-mononitrate treatment prevents cyclosporin A-induced platelet hyperactivation and the underlying nitric oxide-cyclic guanosine-3',5'-monophosphate disturbances.
Reis F; Almeida L; Alcobia T; Santos-Dias JD; Lourenço M; Palmeiro A; Ferrer-Antunes CA; Mesquita JF; Pontes F; Teixeira F
Thromb Res; 2003 May; 110(2-3):107-15. PubMed ID: 12893025
[TBL] [Abstract][Full Text] [Related]
19. Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets.
Bani D; Bigazzi M; Masini E; Bani G; Sacchi TB
Lab Invest; 1995 Nov; 73(5):709-16. PubMed ID: 7474945
[TBL] [Abstract][Full Text] [Related]
20. Long-term smoking impairs platelet-derived nitric oxide release.
Ichiki K; Ikeda H; Haramaki N; Ueno T; Imaizumi T
Circulation; 1996 Dec; 94(12):3109-14. PubMed ID: 8989117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
